Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/1998
08/18/1998US5795570 Method of containing core material in microcapsules
08/18/1998US5795489 Separation of particles from liquid, rotation and filtration
08/18/1998US5795483 Method of separating leukocytes from blood cells using a leukodepletion filter
08/13/1998WO1998035028A2 An oncolytic/immunogenic complementary-adenoviral vector system
08/13/1998WO1998035024A1 New spumavirus isolated from humans
08/13/1998WO1998035014A2 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
08/13/1998WO1998034642A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
08/13/1998WO1998034641A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
08/13/1998WO1998034629A1 Process for preparing synthetic soil-extract materials and medicaments based thereon
08/13/1998WO1998034485A1 METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS
08/13/1998WO1998034478A1 Methods and compositions for producing dried, storage-stable platelets
08/13/1998WO1998011206A3 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
08/13/1998CA2281699A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
08/13/1998CA2280945A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
08/13/1998CA2280820A1 Method of treating blindness with hnt human neuronal cells
08/13/1998CA2280704A1 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
08/13/1998CA2280275A1 New spumavirus isolated from humans
08/13/1998CA2280237A1 An oncolytic/immunogenic complementary-adenoviral vector system
08/13/1998CA2279376A1 Methods and compositions for producing dried, storage-stable platelets
08/12/1998EP0857786A1 RNA dependent amidotransferase B from Staphylococcus Aureus
08/12/1998EP0857785A1 RNA dependent amidotransferase C from Staphylococcus Aureus
08/12/1998EP0857733A2 Hemoglobin having protecting ligands of oxygen binding positions as artificial oxygen carriers for direct biological or medicinal use and process for its preparation
08/12/1998EP0857486A2 Mixture of external membranes and/or cell wall from bacteria for oral immunisation against mucosal infections
08/12/1998EP0857213A1 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening miroorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
08/12/1998EP0857203A2 Methods and compositions to improve germ cell and embryo survival and function
08/12/1998EP0857068A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes
08/12/1998EP0701450B1 Recombinant viruses and their use in gene therapy
08/12/1998EP0643582B1 Method for producing a supernatant of activated thrombocytes
08/12/1998EP0467991B1 Platelet membrane microparticles
08/12/1998CN1190438A Chimeric proteins for use in transport of selected substance into cells
08/12/1998CN1190402A Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
08/12/1998CN1190349A Viral agent associated with mystery swine disease
08/12/1998CN1190348A Method for increasing hematopoietic cell
08/12/1998CN1190346A Pharmaceutical composition comprising lactobacillus plantarum and arginine
08/12/1998CN1190127A Attenuated live neospora vaccine
08/12/1998CN1190019A Ointment for trauma and fracture and its preparation
08/12/1998CN1190004A Burn curing powder
08/11/1998US5792900 Genetic engineered neuron protein for treating nervous system disorder
08/11/1998US5792845 Nucleotides encoding angiostatin protein and method of use
08/11/1998US5792744 Proteins from mammalian liver
08/11/1998US5792643 Cooling an aqueous suspension of virus, saccharide, high-molecular-weight structural additive, an amino acid and buffer and freeze drying maintaining 10% water; gene therapy
08/11/1998US5792508 Materials for treatment of periodontal disease
08/11/1998US5792506 Disulfide bonds are reduced to sulfhydryl decreasing allergenicity of feeds
08/11/1998US5792462 Alphavirus RNA replicon systems
08/11/1998US5792456 Mutant BR96 antibodies reactive with human carcinomas
08/11/1998CA2139284C Automation of plasma sequestration
08/11/1998CA2083162C Enzymatic neutralization of heparin
08/11/1998CA2011111C Cool storage of cultured epithelial sheets
08/07/1998CA2222987A1 Novel compounds
08/07/1998CA2222984A1 Novel rat
08/07/1998CA2222978A1 Novel compounds
08/07/1998CA2222961A1 Novel compounds
08/07/1998CA2197050A1 Anti-cancer agents derived from fertilized incubated shell eggs
08/06/1998WO1998034121A2 Isolated p27 protein and methods for its production and use
08/06/1998WO1998033925A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998WO1998033891A1 Method for the production of selected lymphocytes
08/06/1998WO1998033889A1 Adipocyte culture
08/06/1998WO1998033888A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl
08/06/1998WO1998033527A2 Cancer immunotherapy with semi-allogeneic cells
08/06/1998WO1998033522A1 Infectious bursitis vaccine
08/06/1998WO1998033387A1 Tolerance to natural antibody antigens
08/06/1998CA2279542A1 Tolerance to natural antibody antigens
08/06/1998CA2279490A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998CA2278847A1 Method for the production of selected lymphocytes
08/06/1998CA2278824A1 Infectious bursitis vaccine
08/06/1998CA2278678A1 Cancer immunotherapy with semi-allogeneic cells
08/06/1998CA2278189A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl
08/05/1998EP0856319A2 Device and method for processing blood for human transfusion
08/05/1998EP0856314A1 Immunosuppressant
08/05/1998EP0856259A1 Composition for feed use comprising lyophilized live lactic bacteria
08/05/1998EP0856061A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells
08/05/1998EP0732931A4 Methods for tissue embedding and tissue culturing
08/05/1998CN1189857A Recombinant MVA virus, and the use thereof
08/05/1998CN1189352A Chinese herbal medicine for treating hysteromyoma and breast fibrosarcoma and its prepn. method
08/05/1998CN1189351A Chinese patent drug for treating hyperlipemia
08/05/1998CN1189341A Health instant powder for embryo
08/05/1998CN1189338A Complexing calcium and its prodn. method
08/05/1998CN1189328A Supermicron pearl talcum powder and its prepn. tech.
08/05/1998CN1189326A Supermicron pearl face cream and its prepn. tech.
08/04/1998US5789601 Method of inactivation of viral and bacterial blood contaminants
08/04/1998US5789543 Vertebrate embryonic pattern-inducing proteins and uses related thereto
08/04/1998US5789246 Compositions comprising hepatocyte precursors
08/04/1998US5789151 Preservation of adenosine triphosphate; hemolysis reduction
08/04/1998US5789147 Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
08/04/1998US5788970 Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
08/04/1998US5788968 Oral administration of major histocompatibility complex antigen
08/04/1998US5788964 Method for sensitization of cancer cells for killer cell mediated lysis
08/04/1998US5788963 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
08/04/1998US5788662 Surgical adhesive
07/1998
07/30/1998WO1998032859A1 Multiple site delivery of adenoviral vector for the induction of angiogenesis
07/30/1998WO1998032841A1 Bioartificial hormone releasing device
07/30/1998WO1998032840A1 Method for separating cells
07/30/1998WO1998032457A2 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
07/30/1998WO1998032455A1 The extract of pine needle and the use thereof
07/30/1998WO1998032453A1 Facilitation of wound healing with cm101/gbs toxin
07/30/1998WO1998032452A1 Treatment of chronic inflammatory diseases with cm101/gbs toxin
07/30/1998WO1998032450A1 Bone regeneration in osteoporosis using human bone marrow mesenchymal cells
07/30/1998WO1998032449A1 Process for extracting natural products by means of supercritical fluids
07/30/1998WO1998032448A1 Facilitation of repair of neural injury with cm101/gbs toxin
07/30/1998WO1998022508A3 Process for tumour cell depletion of cd34-positive cells
1 ... 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 ... 1259